TRACON Pharmaceuticals, Inc. (TCON)
NASDAQ: TCON · IEX Real-Time Price · USD
0.430
+0.020 (4.80%)
At close: Mar 28, 2024, 4:00 PM
0.439
+0.009 (2.07%)
After-hours: Mar 28, 2024, 7:59 PM EDT

TRACON Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-3.59-29.14-28.67-16.78-22.67-34.96-19.1-27.01-24.44-7.11
Upgrade
Depreciation & Amortization
0.030.07-0.06-0.010.020.030.050.090.050.02
Upgrade
Share-Based Compensation
1.972.041.781.161.622.673.223.112.090.27
Upgrade
Other Operating Activities
5.260.794.38-1.41-2.621.482.59-3.343.118.28
Upgrade
Operating Cash Flow
3.68-26.24-22.57-17.04-23.65-30.78-13.24-27.15-19.161.76
Upgrade
Capital Expenditures
0-0.02-0.05-0.0100-0.04-0-0.13-0.07
Upgrade
Change in Investments
004-414.02-8.873.712.08-10.790
Upgrade
Investing Cash Flow
0-0.023.95-414.02-8.873.672.07-10.92-0.07
Upgrade
Share Issuance / Repurchase
7.967.9713.3638.162.3136.644.3121.4136.38-1.2
Upgrade
Debt Issued / Paid
-20.511.71-2.8-1.4-1.4-1.32-0.85-20.076.58
Upgrade
Other Financing Activities
-------0.14--25.65
Upgrade
Financing Cash Flow
-12.5419.6810.5636.760.9135.323.3319.4136.4531.04
Upgrade
Net Cash Flow
-8.86-6.57-8.0615.72-8.72-4.33-6.24-5.666.3732.72
Upgrade
Free Cash Flow
3.68-26.26-22.62-17.05-23.65-30.78-13.28-27.15-19.291.69
Upgrade
Free Cash Flow Margin
30.52%--6537.28%---1026.10%-151.71%-787.27%-244.05%46.91%
Upgrade
Free Cash Flow Per Share
0.11-1.25-1.31-1.90-7.79-11.42-7.90-21.42-17.3510.45
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).